Teacher Retirement System of Texas Sells 38,229 Shares of Hims & Hers Health, Inc. (NYSE:HIMS)

Teacher Retirement System of Texas cut its holdings in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 59.4% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 26,093 shares of the company's stock after selling 38,229 shares during the period. Teacher Retirement System of Texas' holdings in Hims & Hers Health were worth $771,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Raymond James Financial Inc. purchased a new position in Hims & Hers Health in the 4th quarter valued at about $18,048,000. O Shaughnessy Asset Management LLC purchased a new stake in Hims & Hers Health in the fourth quarter valued at $208,000. Commonwealth Equity Services LLC lifted its position in Hims & Hers Health by 111.6% in the fourth quarter. Commonwealth Equity Services LLC now owns 58,894 shares of the company's stock valued at $1,424,000 after acquiring an additional 31,062 shares during the last quarter. PNC Financial Services Group Inc. raised its holdings in shares of Hims & Hers Health by 51.9% in the fourth quarter. PNC Financial Services Group Inc. now owns 17,225 shares of the company's stock valued at $417,000 after buying an additional 5,885 shares during the last quarter. Finally, Amundi raised its holdings in shares of Hims & Hers Health by 49.1% in the fourth quarter. Amundi now owns 12,741 shares of the company's stock valued at $328,000 after buying an additional 4,197 shares during the last quarter. 63.52% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other Hims & Hers Health news, CEO Andrew Dudum sold 65,110 shares of the firm's stock in a transaction on Tuesday, June 17th. The stock was sold at an average price of $59.22, for a total transaction of $3,855,814.20. Following the transaction, the chief executive officer directly owned 95,105 shares in the company, valued at approximately $5,632,118.10. This trade represents a 40.64% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Oluyemi Okupe sold 11,581 shares of Hims & Hers Health stock in a transaction on Monday, July 14th. The stock was sold at an average price of $47.70, for a total value of $552,413.70. Following the sale, the chief financial officer owned 54,084 shares in the company, valued at $2,579,806.80. The trade was a 17.64% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 633,126 shares of company stock valued at $33,717,663. Company insiders own 13.71% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the stock. TD Cowen downgraded shares of Hims & Hers Health from a "buy" rating to a "hold" rating and reduced their price objective for the company from $44.00 to $30.00 in a research note on Tuesday, April 29th. Wall Street Zen downgraded shares of Hims & Hers Health from a "buy" rating to a "hold" rating in a research note on Saturday, July 12th. Bank of America lifted their price target on shares of Hims & Hers Health from $22.00 to $26.00 and gave the stock an "underperform" rating in a research note on Tuesday, April 29th. Piper Sandler reissued a "neutral" rating and set a $39.00 price objective (up from $35.00) on shares of Hims & Hers Health in a report on Tuesday, May 6th. Finally, Morgan Stanley reissued an "equal weight" rating and set a $40.00 price objective on shares of Hims & Hers Health in a report on Wednesday, June 11th. Three equities research analysts have rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $39.83.

Hims & Hers Health Stock Performance

Hims & Hers Health stock traded up $0.47 during mid-day trading on Friday, reaching $50.46. The company's stock had a trading volume of 14,351,694 shares, compared to its average volume of 33,456,711. The company has a market capitalization of $11.30 billion, a price-to-earnings ratio of 73.26, a price-to-earnings-growth ratio of 1.91 and a beta of 2.02. Hims & Hers Health, Inc. has a 12 month low of $13.47 and a 12 month high of $72.98. The business's 50 day simple moving average is $53.86 and its 200 day simple moving average is $41.62.

Hims & Hers Health (NYSE:HIMS - Get Free Report) last released its quarterly earnings results on Monday, May 5th. The company reported $0.20 EPS for the quarter, beating the consensus estimate of $0.12 by $0.08. Hims & Hers Health had a net margin of 9.24% and a return on equity of 22.75%. The business had revenue of $586.01 million for the quarter, compared to the consensus estimate of $535.21 million. During the same period in the prior year, the company posted $0.05 earnings per share. Hims & Hers Health's revenue was up 110.7% compared to the same quarter last year. As a group, sell-side analysts expect that Hims & Hers Health, Inc. will post 0.29 EPS for the current year.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.